Effectiveness, safety and indications of acute normovolemic haemodilution in total knee arthroplasty
- PMID: 38332114
- PMCID: PMC10853272
- DOI: 10.1038/s41598-024-53779-6
Effectiveness, safety and indications of acute normovolemic haemodilution in total knee arthroplasty
Abstract
Total knee arthroplasty (TKA) is the most cost-effective, and potent method for the treatment of end-stage knee osteoarthritis. Acute normovolemic haemodilution (ANH) can effectively replace the need for allogeneic transfusions due to the high amount of bleeding during TKA. However, more studies are needed to prove the efficacy and safety of ANH and to clarify its indications in the field of knee replacement. Medical records from June 1, 2019 to June 1, 2021 were searched and grouped according to inclusion and exclusion criteria.
Part i: 58 patients with ANH during TKA were selected as the ANH group (n = 58), and 58 patients with allogeneic transfusion were chosen as the control group (n = 58).
Part ii: Patients with anaemia were divided into the ANH group (n = 18) and the control group (n = 12).
Part i: The postoperative inflammatory index and serum albumin in the ANH group were significantly lower than those in the control group. No significant difference was observed in the theoretical loss of red blood cells, postoperative renal function, liver function, cardiac function and biochemical ion index between the two groups. The effective rate of ANH in the normal haemoglobin group was significantly lower than that in the anaemia group.
Part ii: In patients with anaemia, the theoretical loss of red blood cells in patients with ANH was less than that in the control group. The postoperative inflammation, renal function, liver function and cardiac function in the ANH group were better than those in the control group, and no significant difference was noted in biochemical ions and nutritional status indicators. This paper shows that ANH not only can replace allogeneic transfusion in TKA, especially in patients with anaemia, but also has lower inflammatory indicators than allogeneic transfusion. From a security perspective, the body's tolerance to ANH is within the body's compensation range.
Keywords: Acute normovolemic haemodilution; Indications; Perioperative blood management; Total knee arthroplasty.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection.Ann Surg. 2008 Sep;248(3):360-9. doi: 10.1097/SLA.0b013e318184db08. Ann Surg. 2008. PMID: 18791356 Clinical Trial.
-
Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy.Anesth Analg. 1997 Nov;85(5):953-8. doi: 10.1097/00000539-199711000-00001. Anesth Analg. 1997. PMID: 9356083 Clinical Trial.
-
Mild volume acute normovolemic hemodilution is associated with lower intraoperative transfusion and postoperative pulmonary infection in patients undergoing cardiac surgery -- a retrospective, propensity matching study.BMC Anesthesiol. 2017 Jan 26;17(1):13. doi: 10.1186/s12871-017-0305-7. BMC Anesthesiol. 2017. PMID: 28122491 Free PMC article.
-
Effect of acute normovolemic hemodilution on coronary artery bypass grafting: A systematic review and meta-analysis of 22 randomized trials.Int J Surg. 2020 Nov;83:131-139. doi: 10.1016/j.ijsu.2020.09.016. Epub 2020 Sep 18. Int J Surg. 2020. PMID: 32950743
-
Adjuncts to liver surgery: is acute normovolemic hemodilution useful for major hepatic resections?Adv Surg. 2009;43:259-68. doi: 10.1016/j.yasu.2009.02.012. Adv Surg. 2009. PMID: 19845184 Review.
References
-
- Peng H-M, Wang W, Lin J, Weng X-S, Qian W-W, Wang W-D. Multimodal Peri-articular Injection with Tranexamic Acid can reduce postoperative blood loss versus Intravenous Tranexamic Acid in Total Knee Arthroplasty: A Randomized Controlled Trial. J. Orthopaed. Surg. Res. 2021;16(1):546. doi: 10.1186/s13018-021-02685-y. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical